More than 1,000 Coloradans will have the opportunity to be among the first recipients of a new COVID-19 vaccine. The phase three clinics trial will test the AstraZeneca coronavirus vaccine through..
Some good news in our race for a COVID-19 vaccine. Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.
AstraZeneca's Covid-19 vaccine trial has shown promise producing antibodies in adult and elderly patients, a sign that a viable vaccine could be ready by year-end.